Clinical trials
Diabetic Nephropathies trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
23 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2004 | 1 |
| 2006 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 3 |
| 2014 | 2 |
| 2015 | 2 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 1 |
| 2023 | 1 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 13 |
| Terminated | 5 |
| Recruiting | 3 |
| Unknown status | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bayer | 3 |
| Poitiers University Hospital | 3 |
| Assistance Publique - Hôpitaux de Paris | 2 |
| Boehringer Ingelheim | 2 |
| Bristol-Myers Squibb | 1 |
| CHU de Reims | 1 |
| Centre Hospitalier Universitaire de Nice | 1 |
| Eli Lilly and Company | 1 |
| Janssen Research & Development, LLC | 1 |
| NephroGenex, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetic Nephropathies | 23 |
| Diabetes Mellitus, Type 2 | 6 |
| Kidney Diseases | 6 |
| Diabetes Mellitus | 4 |
| Renal Insufficiency, Chronic | 4 |
| Diabetes Mellitus, Type 1 | 3 |
| Hypertension | 3 |
| Kidney Failure, Chronic | 3 |
| Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 1 |
| Diabetic Neuropathies | 1 |
Trials
Showing 51 to 23 of 23. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.